Quest Diagnostics Inc. (DGX) — 分析摘要
Quest Diagnostics Inc.(DGX)的市值为22.95十亿美元,最近一年的营收同比增长了+11.8%。净利润率为9.0%。当前市盈率为22.4倍。
核心要点
- 营收同比变化+11.8%
- 净利润率9.0%
- 市盈率22.4倍
与SERVICES-MEDICAL LABORATORIES板块的其他公司相比,DGX的营收增长为+11.8%,市盈率为22.4倍。
Quest Diagnostics Inc. (DGX)
更新 — ET · 来源 POLYGON
红旗与风险提示无重大红旗
基于最新财报,没有触发重大的信用、利润率或趋势红旗。
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
行业
SERVICES-MEDICAL LABORATORIES
员工人数
57,000
总部
SECAUCUS, NJ
Exchange
XNYS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$3.44
股息收益率
1.67%
股息历史
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。